Publications

European journal of nuclear medicine and molecular imaging

Real-world use of PSMA imaging in metastatic castration-sensitive prostate cancer: Findings from the CAPRI-3 registry.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences

Development and validation of an LC-MS/MS method for the quantification of the KRAS^G12C inhibitor divarasib.

Immunity

Functional evaluation of TCR-pMHC pairs at scale allows in silico TCR reactivity prediction.

Molecular cell

An unexpected role for cyclin E-CDK2 in regulating responses to cancer immunotherapy.

Nature reviews. Cancer

Reflecting on 25 years of cancer research: transformative advances and unmet expectations.

Nature medicine

Five-year survival with neoadjuvant therapy in melanoma: updated pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

International journal of cancer

Human Protein Biomarkers Outperform Bacterial Proteins in Colorectal Cancer Detection.

Clinical cancer research : an official journal of the American Association for Cancer Research

The Pharmacologic Profile of ART6043, a First-in-Class Clinical DNA Polymerase Theta Polymerase Domain Inhibitor Potentiating PARP Inhibitor Efficacy.

Neuro-oncology

Health-Related Quality of Life in Glioma Subtypes: A Pooled Analysis of 16 Randomized Trials from the CODAGLIO 2.0 project.

European journal of nuclear medicine and molecular imaging

LiDAR-registered freehand SPECT combined with NIR-fluorescence enables spatial localisation of tracer-avid inguinal lymph nodes: A clinical feasibility study.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

External validation of dose to heart substructures and the association with non-cancer death after SBRT in stage I-II NSCLC patients.

Cancer discovery

Mismatch Repair-Proficient Colorectal Cancer Can Evade Immune Surveillance through an Intrinsic Suppressive Program.

Therapeutic drug monitoring

Impact of Abiraterone Therapeutic Drug Monitoring on Cortisol as a Surrogate Biomarker of CYP17 Inhibition in Metastatic Prostate Cancer Treatment.

The Lancet. Oncology

Personalised medicine in oncology: inequality aversion in a fast-moving field.

The Journal of biological chemistry

"EXPERT" A Practical and Forward-Looking Guide to Capturing Protein Expression and Purification Metadata to develop Machine Learning Models.

29-09-2026

The Lancet. Oncology

Reporting health-related quality of life in randomised clinical trials evaluating adjuvant systemic therapy: recommendations of Common-Sense Oncology and the European Organisation for Research and Treatment of Cancer.

29-09-2026

Cell reports. Medicine

A multi-omics analysis of advanced triple-negative breast cancer identifies predictors to chemo-immunotherapy and on-treatment dynamics.

29-09-2026

Physics in medicine and biology

Robustness of deep learning-based denoising 4DCBCT methods.

28-09-2026

European radiology

ESR Bridges: new developments in imaging and treatment of soft tissue sarcoma-a multidisciplinary view.

28-09-2026

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

A conceptual model of cancer care and lived experiences in adolescents and young adults with cancer: results from the multi-national European STRONG AYA project.

25-09-2026

British journal of cancer

Correction: Safety and efficacy of lapatinib, binimetinib, and vinorelbine for RAS mutant metastatic colorectal cancer: results of the RASTRIC Phase I/II trial.

25-09-2026

European journal of nuclear medicine and molecular imaging

Molecular imaging tracers targeting c-MET: a systematic review of preclinical evidence and clinical translation.

24-09-2026

Blood

DOT1L shapes ncPRC1 target gene repression to maintain germinal center B-cell identity in diffuse large B-cell lymphoma.

24-09-2026

BMJ open

SCOPES-II: short course of preoperative radiotherapy in head and neck, trunk and extremity soft tissue sarcomas - study protocol for a second randomised phase II clinical trial.

23-09-2026

Nature communications

PUM3 is an essential suppressor of replication stress in homologous recombination deficient breast cancer.

ESMO open

Access to cancer clinical trials in Europe: when trial availability does not match patient need.

Cell reports methods

Efficient generation of human cDC1-like cells to detect and enhance tumor-reactive T cells via CD4⁺ T cell help.

Nature communications

Publisher Correction: A ubiquitin chain-feeding mechanism for BRCA1-A.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Unexpected Lack of Efficacy of Liposomal-Encapsulated Daunorubicin/Cytarabine in Pediatric FLT3 Wild-Type Newly Diagnosed AML.

20-09-2026

Methods in molecular biology (Clifton, N.J.)

Monitoring Calcium Dynamics in Pig Intestinal Organoids with FLIM and FRET.

20-09-2026

The EMBO journal

The BRCA1 coiled-coil domain is dispensable for suppression of tandem duplications and tolerance of FANCM loss.

18-09-2026

ESMO open

Advancing cancer care for adolescents and young adults: the role of the European Network of Expertise.

18-09-2026

Cancer immunology research

Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial.

17-09-2026

Medical image analysis

Associations between spatial distribution of immune cell subsets and clinical outcomes in patients with advanced melanoma treated with immune checkpoint inhibitors: results from the PUMA challenge.

17-09-2026

Structure (London, England : 1993)

AlphaBridge: Tools for the analysis of predicted biomolecular complexes.

16-09-2026

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

An Application of Iterative Health Economic Evaluation: An Update on the Early Cost Effectiveness of Whole-Genome Sequencing in Advanced Non-small-Cell Lung Cancer.

The oncologist

The insufficient publication of early-phase clinical trials in oncology.

European journal of cancer (Oxford, England : 1990)

International phase IV field study to validate the European Organisation for Research and Treatment of Cancer questionnaire for assessing the health-related quality of life of cancer survivors: The EORTC QLQ-SURV100.

European journal of cancer (Oxford, England : 1990)

The European Organisation for Research and Treatment of Cancer Quality of Life Group: Past achievements and future priorities in patient-reported outcomes in oncology.

European journal of cancer (Oxford, England : 1990)

Chemotherapy type and survival in young BRCA1/2 carriers with HER2-negative early breast cancer.